Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Efficacy and Safety Study of an Antiarrhythmic Drug to Treat Atrial Fibrillation in Patients With Pacemakers

ClinicalTrials.gov ID: NCT00389792

Public ClinicalTrials.gov record NCT00389792. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 24, 2026, 10:42 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled Study of ATI-2042 in Patients With Paroxysmal Atrial Fibrillation and Pacemakers With Atrial Fibrillation Data Logging Capabilities

Study identification

NCT ID
NCT00389792
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
ARYx Therapeutics
Industry
Enrollment
72 participants

Conditions and interventions

Interventions

  • ATI-2042 Drug
  • ATI-2042 200 mg Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2006
Primary completion
Nov 30, 2008
Completion
Nov 30, 2008
Last update posted
Mar 10, 2009

2006 – 2008

United States locations

U.S. sites
27
U.S. states
21
U.S. cities
27
Facility City State ZIP Site status
ARYx Investigational Site Phoenix Arizona 85306
ARYx Investigational Site Scottsdale Arizona 85251
ARYx Investigational Site Tucson Arizona 85715
ARYx Investigational Site Larkspur California 94939
ARYx Investigational Site Aurora Colorado 80012
ARYx Investigational Site Hollywood Florida 33021
ARYx Investigational Site Jacksonville Beach Florida 32250
ARYx Investigational Site Atlanta Georgia 30309
ARYx Investigational Site Marietta Georgia 30060
ARYx Investigational Site Chicago Illinois 60611
ARYx Investigational Site Towson Maryland 21204
ARYx Investigational Site Saginaw Michigan 48601
ARYx Investigational Site Minneapolis Minnesota 55442
ARYx Investigational Site St Louis Missouri 63110
ARYx Investigational Site Lincoln Nebraska 68506
ARYx Investigational Site Warren Township New Jersey 07059
ARYx Investigational Site Albuquerque New Mexico 87102
ARYx Investigational Site Buffalo New York 14215
ARYx Investigational Site Hershey Pennsylvania 17033
ARYx Investigational Site Wynnewood Pennsylvania 19096
ARYx Investigational Site Charleston South Carolina 29425
ARYx Investigational Site Nashville Tennessee 37203
ARYx Investigational Site Austin Texas 78756
ARYx Investigational Site Houston Texas 77030
ARYx Investigational Site Burlington Vermont 05401
ARYx Investigational Site Newport News Virginia 23601
ARYx Investigational Site Charleston West Virginia 25304

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 13 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00389792, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 10, 2009 · Synced Jul 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00389792 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →